Raphael A Abong
Dados Biográficos
| ID | 9800301 |
|---|---|
| NOME | Raphael A Abong |
| PRENOMES | Raphael A |
| SOBRENOME | Abong |
| ASSINATURA | ABONG R A |
| AFILIAÇÕES | University of Buea |
| ORCID | 0000-0002-7411-1550 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAÇÕES | 0 |
| OBRAS COMO AUTOR | 1 |
| OBRAS COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2021 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2021 |
| ÍNDICE H | 0 |
Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
INTRODUCTION: Onchocerciasis is targeted for elimination mainly with annual community-directed treatment with ivermectin (CDTI). High infection levels have been reported in South-West Cameroon, despite ≥15 years of CDTI. The aim of this study was to assess factors associated with continued onchocerciasis transmission and skin disease. METHODS: A large-scale cross-sectional study was conducted in 2017 in 20 communities in a loiasis-risk area in So…
Sem obras proeminentes nesta página.
Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
INTRODUCTION: Onchocerciasis is targeted for elimination mainly with annual community-directed treatment with ivermectin (CDTI). High infection levels have been reported in South-West Cameroon, despite ≥15 years of CDTI. The aim of this study was to assess factors associated with continued onchocerciasis transmission and skin disease. METHODS: A large-scale cross-sectional study was conducted in 2017 in 20 communities in a loiasis-risk area in So…
Adverse effect (1 obra) · Disease (1 obra) · Environmental health (1 obra) · Helminth infection and control (1 obra) · Immunology (1 obra) · Internal Medicine (1 obra) · Ivermectin (1 obra) · Medicine (1 obra) · Onchocerciasis (1 obra) · Parasites and Host Interactions (1 obra)